Protein expression patterns of cell cycle regulators in operable breast cancer

Abstract

Background-AimTo evaluate the prognostic role of elaborate molecular clusters encompassing cyclin D1, cyclin E1, p21, p27 and p53 in the context of various breast cancer subtypes.MethodsCyclin E1, cyclin D1, p53, p21 and p27 were evaluated with immunohistochemistry in 1077 formalin-fixed paraffin-embedded tissues from breast cancer patients who had been treated within clinical trials. Jaccard distances were computed for the markers and the resulted matrix was used for conducting unsupervised hierarchical clustering, in order to identify distinct groups correlating with prognosis.ResultsLuminal B and triple-negative (TNBC) tumors presented with the highest and lowest levels of cyclin D1 expression, respectively. By contrast, TNBC frequently expressed Cyclin E1, whereas ER-positive tumors did not. Absence of Cyclin D1 predicted for worse OS, while absence of Cyclin E1 for poorer DFS. The expression patterns of all examined proteins yielded 3 distinct clusters; (1) Cyclin D1 and/or E1 positive with moderate p21 expression; (2) Cyclin D1 and/or E1, and p27 positive, p53 protein negative; and, (3) Cyclin D1 or E1 positive, p53 positive, p21 and p27 negative or moderately positive. The 5-year DFS rates for clusters 1, 2 and 3 were 70.0%, 79.1%, 67.4% and OS 88.4%, 90.4%, 78.9%, respectively.ConclusionsIt seems that the expression of cell cycle regulators in the absence of p53 protein is associated with favorable prognosis in operable breast cancer.

Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21 in vitro and in vivo

“…Prabhu et al reported that overexpression of p21 in human osteosarcoma cells protected against etoposideinduced cell death [31]. Zagouri et al reported that overexpression of p21 was associated with a poor prognosis of breast cancer patients [32]. P21 protein is still regarded as a protein with dual behavior, as its expression can be beneficial or disadvantageous in patients [33].…”

The inhibitory effects of COL1A2 on colorectal cancer cell proliferation, migration, and invasion

“…CCND1 contributes to tumorigenesis through crosstalk with the retinoblastoma tumor suppressor protein and alteration of cell cycle phases. Mutation and overexpression of CCND1 are frequently observed in various cancer types 39 - 41 . IRS-1 is a substrate of the insulin receptor tyrosine kinase, and its high expression is correlated with low tumor cell invasiveness in some cancer types.…”

Circulating miR‐15b, miR‐34a and miR‐218 as promising novel early low‐invasive biomarkers of cervical carcinogenesis

“…3). CCND1, CCNE1 and BCL‐2 proteins are involved in cell cycle advancement and are often overexpressed in cancer (26–28). Although the best‐described function of MSH‐2 is in the DNA mismatch repair system, other functions have been ascribed to this protein (29).…”